Treatment of relapsed small cell lung cancer

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

1997 • 474 citations

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

1992 • 443 citations

Treatment of Brain Metastases of Small-Cell Lung Cancer: Comparing Teniposide and Teniposide With Whole-Brain Radiotherapy—A Phase III Study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group

2000 • 239 citations

Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.

1990 • 217 citations

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer

1998 • 176 citations

Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial

1989 • 170 citations

Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy

1987 • 155 citations

Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

1993 • 148 citations

Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.

1988 • 131 citations

Activity of docetaxel (Taxotere) in small cell lung cancer

1994 • 130 citations

Reinduction chemotherapy in small cell lung cancer

1987 • 121 citations

Paclitaxel and Carboplatin in the Treatment of Small-Cell Lung Cancer Patients Resistant to Cyclophosphamide, Doxorubicin, and Etoposide: A Non–Cross-Resistant Schedule

1999 • 114 citations

Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study

1998 • 95 citations

Phase II Study of Vinorelbine in Heavily Previously Treated Small Cell Lung Cancer

1996 • 74 citations

Small-Cell Carcinoma of Lung: Reinduction Therapy After Late Relapse

1983 • 71 citations

Second-line chemotherapy and its evaluation in small cell lung cancer

1999 • 69 citations

Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.

1992 • 67 citations

Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer

1993 • 58 citations

First-line chemotherapy rechallenge after relapse in small cell lung cancer

1988 • 54 citations

Textbook of Lung Cancer

1999 • 47 citations

"Salvage" radiation therapy for intrathoracic small cell carcinoma of the lung progressing on combination chemotherapy.

1983 • 37 citations

Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: A phase II study of the EORTC lung cancer cooperative group

1993 • 29 citations

Response to Thoracic Radiotherapy in Patients with Small Cell Carcinoma of the Lung After Failure of Combination Chemotherapy

1979 • 23 citations

Second-line chemotherapy in small cell lung cancer

1990 • 21 citations

Radiation therapy for chest recurrences following induction chemotherapy in small cell lung cancer

1991 • 18 citations

Brain metastases from small cell lung cancer: Chemotherapy, radiotherapy, or both?

1995 • 18 citations

Teniposide (VM26) as second-line treatment for small cell lung cancer

1991 • 5 citations

Cited By (0)

Loading...